Lundbeck
HLUN-B.CO
£3.30
Share price
2.43%
Change (1 day)
-13.92%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
EPS for Lundbeck (HLUN-B.CO)
EPS in 2023 (TTM): £0.29
According to Lundbeck 's latest financial reports the company's current EPS (TTM) is £0.27. In 2022 the company made an earnings per share (EPS) of £0.20 a decrease over its 2021 EPS that were of £0.46.
EPS history for Lundbeck from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | £0.29 | 43.65% |
| 2022 | £0.20 | -55.47% |
| 2021 | £0.46 | -51.83% |
| 2020 | £0.95 | -28.01% |
| 2019 | £1.32 | -44.08% |
| 2018 | £2.36 | 51.94% |
| 2017 | £1.56 | 126.64% |
| 2016 | £0.69 | -120.84% |
| 2015 | -£3.29 | 5622.18% |
| 2014 | -£0.05756 | -110.03% |
| 2013 | £0.57 | -28.08% |
| 2012 | £0.80 | -52.1% |
| 2011 | £1.67 | -1.31% |
| 2010 | £1.69 | 15.61% |
| 2009 | £1.46 |